Table 2. Pathologic and oncologic outcomes.
| Pathologic and oncologic outcomes | CLS (n=59) | SILS+1 (n=58) | P |
|---|---|---|---|
| Tumor diameter | 2.1±1.0 | 2.2±1.0 | 0.392 |
| Pathologic TNM stage | 0.236 | ||
| I | 30 (50.9) | 37 (63.8) | |
| II | 14 (23.7) | 13 (22.4) | |
| III | 15 (25.4) | 8 (13.8) | |
| Differentiation | 0.807 | ||
| Good | 2 (3.4) | 2 (3.4) | |
| Moderate | 25 (42.4) | 28 (48.3) | |
| Poor/other | 32 (54.2) | 28 (48.3) | |
| Depth of invasion | 0.116 | ||
| T1 | 20 (33.9) | 25 (43.1) | |
| T2 | 13 (22.0) | 18 (31.0) | |
| T3–4a | 26 (44.1) | 15 (25.9) | |
| Harvested No. of LN | 33.0±14.0 | 31.2±13.1 | 0.484 |
Data are presented as mean ± standard deviation or n (%). CLS, conventional laparoscopic surgery; SILS+1, single-incision plus one-port laparoscopic surgery; TNM, tumor-node-metastasis; LN, lymph node.